Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,276–4,300 of 7,816 matching trials · page 172 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Physical Activity to Patients With Dementia and Their Caregivers. NCT02044887 physical activity Runs in: Spain · 1 site |
NA other |
COMPLETED | 140 | Fundacion para la Investigacion y Formacion en Ciencias de la Salud OTHER |
2022-11-23 |
|
A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease NCT04520412 GV-971; Placebo Runs in: Australia; Canada; China; Czechia; France; Hong Kong; Net... · 171 sites |
PHASE3 other |
SUSPENDED | 2,046 | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. INDUSTRY |
2022-11-23 |
|
Detecting Probable Alzheimer's Disease From Speech Using Linguistical Analysis NCT04041895 Audio speech recording Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | East Tennessee State University OTHER |
2022-11-22 |
|
Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia NCT05371639 Tian Ma Bian Chun Zhi Gan Tablets; Placebo Runs in: China · 1 site |
PHASE2 other |
UNKNOWN | 360 | Dongzhimen Hospital, Beijing OTHER |
2022-11-22 |
|
Modulators of Gamma tACS in Alzheimer's Disease (Mod-GammAD) NCT04842955 Gamma tACS (40 Hz) over the superior parietal cortex; Sham tACS ove... Runs in: Italy · 1 site |
NA other |
COMPLETED | 60 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia OTHER |
2022-11-21 |
|
Advance Care Planning (ACP) in Primary Care for Dementia NCT05322317 ADVANCE-PC training via ECHO Runs in: United States · 1 site |
NA other |
COMPLETED | 17 | Oregon Health and Science University OTHER |
2022-11-18 |
|
Preliminary Randomised Evaluation of Singing in Dementia NCT05573750 Singing group Runs in: United Kingdom · 2 sites |
NA other |
UNKNOWN | 160 | University of Nottingham OTHER |
2022-11-18 |
|
To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia NCT04311515 Tau Positron emission tomography (PET); Fluorodeoxyglucose (FDG) Po... Runs in: United States · 10 sites |
PHASE2 other |
TERMINATED | 4 | Samus Therapeutics, Inc. INDUSTRY |
2022-11-17 |
|
EGb 761 in the Syndrome of MCI With Concomitant CVD NCT04525144 Tebonin Forte Runs in: Singapore · 1 site |
PHASE2 other |
RECRUITING | 134 | National Neuroscience Institute OTHER |
2022-11-17 |
|
Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease NCT04984330 Selinexor; Dexamethasone Runs in: United States · 1 site |
EARLY_PHASE1 other |
WITHDRAWN | 0 | Weill Medical College of Cornell University OTHER |
2022-11-17 |
|
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia NCT05497817 Algorithm; Random Match |
NA other |
WITHDRAWN | 0 | Mayo Clinic OTHER |
2022-11-17 |
|
Amisulpride Treatment for BPSD in AD Patients NCT04341467 Amisulpride; Olanzapine Runs in: China · 1 site |
NA other |
UNKNOWN | 76 | Tianjin Anding Hospital OTHER |
2022-11-16 |
|
Longitudinal Observation of NHS Staff Wellbeing Following Introduction of the I-care Peer Support App NCT04809961 I-care app Runs in: United Kingdom · 1 site |
NA other |
WITHDRAWN | 0 | University of Southampton OTHER |
2022-11-16 |
|
Auditory Slow Wave Enhancement in Parkinson Disease and Mild Cognitive Impairment NCT04736017 TSB Axo Runs in: Switzerland · 1 site |
NA other |
UNKNOWN | 48 | University of Zurich OTHER |
2022-11-15 |
|
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease NCT04804618 Runs in: China · 1 site |
NA other |
UNKNOWN | 650 | Guangzhou University of Traditional Chinese Medicine OTHER |
2022-11-15 |
|
Measuring the Impact of a Socially Assistive Robot NCT04848155 socially assistive robot Runs in: Belgium · 1 site |
NA other |
COMPLETED | 120 | University Ghent OTHER |
2022-11-15 |
|
The Dampness Syndrome of Chinese Medicine Cohort Study NCT05315895 natural aging process Runs in: China · 1 site |
NA other |
RECRUITING | 100,000 | Guangzhou University of Traditional Chinese Medicine OTHER |
2022-11-15 |
|
Exercise for Young Adults With Cancer NCT05613699 Exercise - Social Media; Exercise - App; Exercise - closed to patie... Runs in: Germany · 1 site |
NA other |
COMPLETED | 106 | University Hospital Heidelberg OTHER |
2022-11-14 |
|
CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease NCT00087789 CERE-110: Adeno-Associated Virus Delivery of NGF Runs in: United States · 2 sites |
PHASE1 gene-therapy |
COMPLETED | 10 | Sangamo Therapeutics INDUSTRY |
2022-11-10 |
|
Long-term Tablet-computer Based Casual Puzzle Video Game Intervention in Healthy Older and Cognitively Impaired Persons NCT03139799 Experimental - Puzzle Video Game Intervention; Control - Tablet New... Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 15 | University of Bern OTHER |
2022-11-10 |
|
Caregiving and Racial Considerations During a Pandemic Online Training Education NCT04732715 CaRE Course Runs in: United States · 1 site |
NA other |
COMPLETED | 75 | Emory University OTHER |
2022-11-10 |
|
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease NCT03352557 BIIB092; Placebo Runs in: Australia; France; Germany; Italy; Japan; Poland; Spain; ... · 101 sites |
PHASE2 other |
TERMINATED | 654 | Biogen INDUSTRY |
2022-11-08 |
|
Effectiveness of an Online Training and Support Program (iSupport) for Informal Dementia Caregivers NCT04104568 iSupport for dementia - European-Portuguese version; e-book (comparator) Runs in: Portugal · 1 site |
NA other |
SUSPENDED | 184 | Universidade do Porto OTHER |
2022-11-08 |
|
Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease NCT00722046 PF-04360365 0.1 mg/kg; PF-04360365 0.5 mg/kg; PF-04360365 1 mg/kg; ... Runs in: Australia; Belgium; Canada; South Korea; United Kingdom; ... · 42 sites |
PHASE2 other |
COMPLETED | 198 | Pfizer INDUSTRY |
2022-11-07 |
|
CuidaTXT: a Text Message Dementia-caregiver Intervention for Latinos NCT04316104 CuidaTXT Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 24 | University of Kansas Medical Center OTHER |
2022-11-07 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial